# Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus

> **NCT07100613** · PHASE2 · RECRUITING · sponsor: **University of Palermo** · enrollment: 45 (estimated)

## Conditions studied

- Oral Lichen Planus
- Oral Lichen Planus Related Stress
- Oral Mucosal Disease
- Oral Pain

## Interventions

- **DRUG:** Clobetasol Patch
- **DRUG:** Clobetasol + Resveratrol Patch
- **DRUG:** Clobetasol in Orabase

## Key facts

- **NCT ID:** NCT07100613
- **Lead sponsor:** University of Palermo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-04
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07100613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07100613, "Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07100613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*